Description:  The Treatment of Lead-Exposed Children (TLC) trial was a placebo-controlled, randomized study of succimer (a chelating agent) in children with blood lead levels of 20-44 micrograms/dL.These data consist of four repeated measurements of blood lead levels obtained at baseline (or week 0), week 1, week 4, and week 6 on 100 children who were randomly assigned to chelation treatment with succimer or placebo.
Reference: Treatment of Lead-exposed Children (TLC) Trial Group. (2000). Safety and Efficacy of Succimer in Toddlers with Blood Lead Levels of 20-44 µg/dL.  Pediatric Research, 48, 593-599.
Source: Data courtesy of Dr. George G. Rhoads (Chair, TLC Steering Committee).
Subsample (N=100) of data on Blood Lead Levels from the Treatment of Lead Exposed Children (TLC) Trial.